STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICUI
  4. [Form 4] ICU MEDICAL INC/DE Insider Trading Activity

ICU Medical (ICUI) director Elisha Finney sells 378 shares at about $182

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

ICU Medical Inc. director Elisha W. Finney sold common shares, disposing of 378 shares of ICU Medical Inc. common stock on 2026-08-11 in an open market or private transaction at a weighted average price of $182.4818 per share. The trades occurred in a price range from $182.4808 to $182.5701. Following this transaction, Finney directly holds 4,871 common shares of ICU Medical Inc.

Positive

  • None.

Negative

  • None.
Insider FINNEY ELISHA W
Role Director
Sold 378 shs ($69K)
Type Security Shares Price Value
Sale Common Stock F1 378 $182.4818 $69K
Holdings After Transaction: Common Stock — 4,871 shares (Direct)
Footnotes (1)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares sold 378 shares Non-derivative common stock sale on 2026-08-11
Weighted average sale price $182.4818 per share Reported for ICUI common stock sale
Sale price range low $182.4808 per share Lowest price in multiple sale transactions
Sale price range high $182.5701 per share Highest price in multiple sale transactions
Shares held after transaction 4,871 shares Director’s direct common stock holdings post-sale
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"Transaction code S indicates a sale in open market or private transaction."
non-derivative financial
"The transaction_type is non-derivative for common stock."

FAQ

What insider transaction did ICU Medical (ICUI) report for Elisha W. Finney?
ICU Medical (ICUI) reported that director Elisha W. Finney sold 378 common shares on 2026-08-11. The sale was reported as an open market or private transaction, with details filed on Form 4.

At what price did Elisha W. Finney sell ICUI shares?
The reported weighted average sale price was $182.4818 per ICUI share. According to the disclosure, the 378 shares were sold in multiple trades at prices ranging from $182.4808 to $182.5701 per share.

How many ICU Medical (ICUI) shares does Elisha W. Finney hold after the sale?
After the reported sale, Elisha W. Finney directly holds 4,871 shares of ICU Medical common stock. This figure reflects her post-transaction position as disclosed in the Form 4 filing.

Was the ICUI insider sale by Elisha W. Finney under a Rule 10b5-1 plan?
The filing’s 10b5-1 checkbox is not marked as using a trading plan. The sale is described as a standard open market or private transaction, with no Rule 10b5-1 plan noted in the disclosure.

How many ICUI shares were sold in total in this insider transaction?
The Form 4 reports that 378 ICU Medical common shares were sold in this transaction. All shares are classified as directly owned, non-derivative securities, and were executed on 2026-08-11.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FINNEY ELISHA W
(Last)(First)(Middle)
951 CALLE AMANECER
(Street)
SAN CLEMENTE CALIFORNIA 92673
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/11/2026S378D$182.4818(1)4,871D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
By: Paula Darbyshire, Attorney-in-Fact For: Elisha W Finney08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR